Check out the companies making headlines before the bell: Johnson & Johnson – J&J shares rose roughly 1% in the premarket after the company beat quarterly forecasts and raised its earnings outlook amid strong sales of drugs and medical devices. J&J reported adjusted quarterly earnings of $2.48 per share, beating the $2.27 consensus estimate, with revenue
0 Comments
In this article NTGR CROX LUV WHR ULVR-GB A customer selects bar of Dove soap, a Unilever product, at a Sainsbury’s supermarket in London, U.K. Bloomberg | Getty Images Check out the companies making headlines before the bell Thursday: Netgear – Netgear shares plummeted 14.2% after the computer equipment maker reported lower-than-expected sales and revenue
0 Comments
Inarguably, one of the current century’s biggest investment narratives has been the rise of China stocks. Once a mess of an economy suffering from an identity crisis, the Asian juggernaut embraced Western-style capitalism — at least in its business dealings. Quickly, the so-called Chinese miracle occurred, catapulting the nation to an economic powerhouse second only
0 Comments
In financial and managerial accounting, inherent risk is defined as the possibility of incorrect or misleading information in accounting statements resulting from something other than the failure of controls. Incidents of inherent risk are most common where accountants have to use a larger than normal amount of judgment and approximation, or where complex financial instruments
0 Comments
Over the last few months, I’ve generally been bullish on the upside potential of Churchill Capital Corp IV (NYSE:CCIV), the special purpose acquisition company that’s about to merge — barring unusual circumstances — with Lucid Motors, an electric vehicle manufacturer that could potentially challenge competitor in the space Tesla (NASDAQ:TSLA). Admittedly, though, it’s difficult not
0 Comments
In this article CYDY Young chemist working with chemical substances during scientific experiment in laboratory. skynesher | E+ | Getty Images Company: CytoDyn Inc. (CYDY) Business: CytoDyn is a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its
0 Comments
In this article HON TWTR INTC SAM SNAP Pedestrians walk past Skechers shoes displayed outside of a store in San Francisco, California. Getty Images Check out the companies making headlines before the bell Friday: American Express – American Express gained 3.3% after reporting quarterly earnings of $2.80 per share. That beat the consensus estimate of
0 Comments
Bond prices fluctuate with changing market sentiments and economic environments, but bond prices are affected in a much different way than stocks. Risks such as rising interest rates and economic stimulus policies have an effect on both stocks and bonds, but each reacts in an opposite way. Stocks versus Bonds When stocks are on the rise, investors
0 Comments